Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADIANA Trial: Outpatient Management of Acute Uncomplicated Diverticulitis With vs Without Antibiotics
2025-523121-17-00Phase 4Authorised
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin + clavulanate in diverticular disease, sigmoid diverticulitis and diverticulitis (2 arms), sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoint: Therapeutic failure rate (early and at one month). Planned start Apr 2026; status: authorised.
02
Drugs
amoxicillin + clavulanate
03
Conditions
diverticular diseasesigmoid diverticulitisdiverticulitis
Beyond the preview
Go deeper on 2025-523121-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523121-17-00.